Literature DB >> 11534865

Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells.

Y Etzion1, Y Grossman.   

Abstract

The effects of low concentrations of 4-aminopyridine (4-AP) on the membrane properties of guinea pig cerebellar Purkinje cells were investigated in slice preparation using intracellular recordings. It was found that 1-10 microM 4-AP did not affect the resting potential or the input resistance of the cells, but reduced markedly the duration of the slowly depolarizing potential (SDP), and thus the latency to the firing of Ca2+ spikes in response to intracellular current pulses. Intradendritic recordings in the presence of tetrodotoxin, Cd2+, and low [Ca2+]o, which blocked all the regenerative responses, exhibited prominent membrane outward rectification in response to depolarizing current pulses. Under these conditions, the SDP was abolished and, in contrast, a slowly developing hyperpolarization was consistently observed. Application of 10 microM 4-AP reduced the outward membrane rectification in a reversible manner, but did not affect the transient hyperpolarization, which is usually attributed to the activation of potassium "A" current. These results demonstrate, for the first time, the presence of a highly 4-AP sensitive delayed rectifier in guinea pig cerebellar Purkinje cells, which prominently affects their excitability. The results also indicate that the slowly depolarizing potential of guinea pig Purkinje cells does not involve inactivation of transient potassium currents, which has been suggested previously as an underlying mechanism for this phenomenon in turtle Purkinje cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534865     DOI: 10.1007/s002210100788

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  25 in total

1.  Current treatment of vestibular, ocular motor disorders and nystagmus.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Role of cerebellum in motion perception and vestibulo-ocular reflex-similarities and disparities.

Authors:  Aasef G Shaikh; Antonella Palla; Sarah Marti; Itsaso Olasagasti; Lance M Optican; David S Zee; Dominik Straumann
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

3.  The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.

Authors:  Karina Alviña; Kamran Khodakhah
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

4.  Kv1 channels selectively prevent dendritic hyperexcitability in rat Purkinje cells.

Authors:  Simin Khavandgar; Joy T Walter; Kristin Sageser; Kamran Khodakhah
Journal:  J Physiol       Date:  2005-10-06       Impact factor: 5.182

5.  A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

Authors:  M Strupp; R Kalla; J Claassen; C Adrion; U Mansmann; T Klopstock; T Freilinger; H Neugebauer; R Spiegel; M Dichgans; F Lehmann-Horn; K Jurkat-Rott; T Brandt; J C Jen; K Jahn
Journal:  Neurology       Date:  2011-07-06       Impact factor: 9.910

6.  4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.

Authors:  O Kremmyda; A Zwergal; C la Fougère; T Brandt; K Jahn; M Strupp
Journal:  J Neurol       Date:  2012-11-24       Impact factor: 4.849

7.  Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine.

Authors:  K Feil; J Claaßen; S Bardins; J Teufel; M Habs; R Kalla; M Strupp
Journal:  J Neurol       Date:  2013-04-18       Impact factor: 4.849

Review 8.  Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.

Authors:  Katharina Feil; Tatiana Bremova; Carolin Muth; Roman Schniepp; Julian Teufel; Michael Strupp
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

Review 9.  Aminopyridines for the treatment of neurologic disorders.

Authors:  Michael Strupp; Julian Teufel; Andreas Zwergal; Roman Schniepp; Kamran Khodakhah; Katharina Feil
Journal:  Neurol Clin Pract       Date:  2017-02

10.  Dalfampridine in patients with downbeat nystagmus--an observational study.

Authors:  Jens Claassen; Katharina Feil; Stanislav Bardins; Julian Teufel; Rainer Spiegel; Roger Kalla; Erich Schneider; Klaus Jahn; Roman Schniepp; Michael Strupp
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.